Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Niu

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic CancerAnnie A Wu, Katherine M Bever, Won Jin Ho, et al.
Gastroenterology|July 28, 2023
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic CancerYao Xu, Juan Fu, MacKenzie Henderson, et al.
Science Advances|February 7, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cellsJunke Wang, Jessica Gai, Tengyi Zhang, et al.
Nature Communications|July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trialNan Niu, Jinqi Xue, Guanglei Chen, et al.
Nature Communications|November 17, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancerNan Niu, Fang Qiu, Qianshi Xu, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic CancerAnnie A Wu, Katherine M Bever, Won Jin Ho, et al.
Gastroenterology|July 28, 2023
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic CancerYao Xu, Juan Fu, MacKenzie Henderson, et al.
Science Advances|February 7, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cellsJunke Wang, Jessica Gai, Tengyi Zhang, et al.
Nature Communications|July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trialNan Niu, Jinqi Xue, Guanglei Chen, et al.
Nature Communications|November 17, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancerNan Niu, Fang Qiu, Qianshi Xu, et al.
Pageof 12